Diane E Griffin Selected Research

Glutamine (L-Glutamine)

1/2017	Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.
10/2016	Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
1/2016	Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage.
4/2015	Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane E Griffin Research Topics

Disease

70	Infections 09/2023 - 01/2002
41	Measles 01/2023 - 01/2002
23	Encephalomyelitis (Myeloencephalitis) 09/2023 - 06/2003
16	Virus Diseases (Viral Diseases) 09/2023 - 02/2002
8	Alphavirus Infections 01/2021 - 11/2002
8	Exanthema (Rash) 01/2020 - 08/2005
7	Paralysis (Palsy) 09/2023 - 04/2004
5	COVID-19 10/2022 - 12/2020
5	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2002
4	Coinfection 01/2017 - 04/2002
4	Viremia 04/2014 - 08/2005
3	Central Nervous System Infections (Central Nervous System Infection) 05/2024 - 03/2006
3	Poliomyelitis (Polio) 06/2010 - 10/2006
2	Subacute Sclerosing Panencephalitis (SSPE) 01/2020 - 01/2018
2	Zika Virus Infection 01/2019 - 01/2017
2	Hemorrhage 03/2018 - 01/2018
2	Reinfection 01/2018 - 04/2014
2	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2012
2	Rubella (German Measles) 04/2016 - 11/2007
2	Mumps 04/2016 - 11/2007
2	Hypersensitivity (Allergy) 07/2010 - 10/2002
2	HIV Infections (HIV Infection) 10/2009 - 09/2008
1	Melanoma (Melanoma, Malignant) 01/2023
1	Chikungunya Fever 12/2022
1	Arthritis (Polyarthritis) 01/2021
1	Necrosis 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Congenital Abnormalities (Deformity) 01/2017

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 01/2023 - 04/2003
22	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
19	RNA (Ribonucleic Acid)IBA 05/2024 - 04/2002
16	Viral RNAIBA 01/2022 - 06/2003
12	Measles VaccineIBA 01/2018 - 01/2002
11	CytokinesIBA 09/2023 - 01/2002
11	Antiviral Agents (Antivirals)IBA 09/2023 - 01/2013
10	InterferonsIBA 10/2022 - 11/2002
9	AntibodiesIBA 01/2022 - 03/2003
8	Interleukin-10 (Interleukin 10)IBA 01/2022 - 10/2002
8	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 10/2002
7	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 09/2003
7	Neutralizing AntibodiesIBA 04/2016 - 11/2003
5	Immunoglobulin G (IgG)IBA 01/2022 - 11/2007
5	Immunoglobulin M (IgM)IBA 03/2018 - 08/2007
5	Glutamic Acid (Glutamate)FDA Link 10/2016 - 04/2004
5	Formaldehyde (Formol)FDA Link 04/2010 - 01/2002
4	HydrolasesIBA 12/2022 - 01/2018
4	AntigensIBA 01/2022 - 03/2003
4	Interleukin-12 (IL 12)IBA 01/2020 - 01/2002
4	Messenger RNA (mRNA)IBA 01/2019 - 01/2013
4	InterleukinsIBA 01/2017 - 10/2002
4	Glutamine (L-Glutamine)FDA Link 01/2017 - 04/2015
4	Interleukin-4 (Interleukin 4)IBA 01/2017 - 01/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
3	ChemokinesIBA 01/2020 - 10/2016
3	DiazooxonorleucineIBA 01/2017 - 04/2015
3	propionic acid (potassium propionate)IBA 01/2016 - 04/2004
2	Immunologic Factors (Immunomodulators)IBA 09/2023 - 01/2017
2	Interferon Regulatory FactorsIBA 09/2023 - 01/2019
2	Interleukin-18 (Interleukin 18)IBA 01/2023 - 01/2017
2	InflammasomesIBA 01/2023 - 10/2016
2	Complement System Proteins (Complement)IBA 01/2022 - 09/2003
2	Peptides (Polypeptides)IBA 01/2021 - 06/2007
2	EpitopesIBA 11/2019 - 06/2007
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 04/2016 - 06/2007
2	talampanelIBA 01/2016 - 03/2008
2	GYKI 52466IBA 01/2016 - 03/2008
2	Interferon LambdaIBA 04/2015 - 07/2013
2	LipidsIBA 10/2008 - 06/2002
2	AMPA Receptors (AMPA Receptor)IBA 03/2008 - 04/2004
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 03/2008 - 04/2004
2	Inactivated VaccinesIBA 01/2008 - 01/2002
2	Immunoglobulins (Immunoglobulin)IBA 06/2007 - 11/2003
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 09/2023
1	NLR ProteinsIBA 01/2023
1	PyrinIBA 01/2023
1	Caspase 1 (ICE Protease)IBA 01/2023
1	phorbol-12-myristateIBA 01/2023
1	remdesivirIBA 01/2023
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2022
1	Small Interfering RNA (siRNA)IBA 10/2022
1	Poly AIBA 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	Antiviral Restriction FactorsIBA 10/2022
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Biological FactorsIBA 12/2019
1	Prokaryotic Initiation Factor-2IBA 12/2019
1	Combined VaccinesIBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	ADP-ribosylarginine hydrolaseIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2017
1	E 10 (E-10)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Nucleocapsid ProteinsIBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2009